Form 4: Surgery Partners Director Acquires Shares in Recent Transaction
SEC Form 4 Filing
Clifford G. Adlerz, a director at Surgery Partners, Inc., acquired 4,192 shares of common stock at a price of $38.16 on June 1, 2023.
Summary
- On June 1, 2023, Clifford G. Adlerz, a director of Surgery Partners, Inc., acquired 4,192 shares of common stock.
- The acquisition price was $38.16 per share.
- Following the transaction, Adlerz directly owns 44,403 shares of Surgery Partners, Inc.
- The shares acquired will vest on June 1, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing indicating a director's stock purchase. While insider buying can be seen as a positive signal, it's not overwhelmingly positive without additional context.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's future performance.
Industry Context
This Form 4 filing is a routine disclosure related to insider trading. It provides transparency into the transactions of company insiders, which is a standard practice in the financial industry.
Stakeholder Impact
- Shareholders may view the director's stock purchase as a positive sign of confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 06/01/2023 | Date of transaction: Director acquired shares. |
| 06/01/2024 | Vesting date for the acquired shares. |
| 04/05/2024 | Date of signature for the filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.